Cargando…
Highly Stable Silver(I) Complexes with Cyclen-Based Ligands Bearing Sulfide Arms: A Step Toward Silver-111 Labeled Radiopharmaceuticals
[Image: see text] With a half-life of 7.45 days, silver-111 (β(max) 1.04 MeV, E(γ) 245.4 keV [I(γ) 1.24%], E(γ) 342.1 keV [I(γ) 6.7%]) is a promising candidate for targeted cancer therapy with β(–) emitters as well as for associated SPECT imaging. For its clinical use, the development of suitable li...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American
Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009516/ https://www.ncbi.nlm.nih.gov/pubmed/32658468 http://dx.doi.org/10.1021/acs.inorgchem.0c01405 |